Dow Up 2.00% Nasdaq Up 1.66%

Novo Nordisk A/S (NVO)

-NYSE
48.80 Up 0.18(0.37%) Feb 12, 4:02PM EST
|After Hours : 48.80 0.00 (0.00%) Feb 12, 5:43PM EST
Prev Close:48.62
Open:48.85
Bid:48.00 x 500
Ask:52.77 x 100
1y Target Est:60.10
Beta:0.348049
Next Earnings Date:N/A
Day's Range:48.04 - 48.91
52wk Range:43.70 - 60.34
Volume:1,403,708
Avg Vol (3m):1,413,130
Market Cap:124.33B
P/E (ttm):23.87
EPS (ttm):2.04
Div & Yield:0.73 (1.50%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.37%124.33B
PFEUp 0.79%181.25B
LLYDown 0.21%75.47B

Key Statistics

Forward P/E (1 yr):19.92
P/S (ttm):7.60
Ex-Dividend Date:19-Mar-15

Analysts

Annual EPS Est (Dec-16) :2.26
Quarterly EPS Est (Mar-16) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):1.87

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback